A research has shown that "Gas Whal Myung Su (digestive drink)," the flagship product of Dongwha Pharm, prevents pregnant women from eating normal food and has a negative impact on weight gain.
The health authorities found out that Donghwa Pharm had taken animal clinical tests and received data from Dongwha Pharm to analyze them, the Money Today reported on March 25.
According to the pharmaceutical industry on March 24, Dongwha Pharm conducted the clinical test of "corydalis tuber," one of the key ingredients of Gas Whal Myung Su, on mice last year. The corresponding clinical trial was conducted at a local contract research organization (CRO).
Clinical results showed that the dose group of 500 mg and 1,000 mg for pregnant female mice did not gain weight normally. The 1,000 mg administration found that the feed was not properly fed, according to the media report.
This can be interpreted as a sign that corydalis tuber hindered the supply of nutrition through food intake and negatively affected weight gain. An autopsy showed no abnormalities in the weight, intestines or skeletons of the baby rats, it reported.
The clinical tests began in January last year and lasted for 10 months until the final report was made in October of the same year.
Dongwha Pharm did not inform the Ministry of Food and Drug Safety because it had no obligation to report the results. The ministry has only recently discovered this fact and started analyzing the full text of clinical reports from Dongwha Pharm.